Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation is allowed to use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website for educational purpose only. Bodily introduction of any kind into humans and animals is strictly forbidden by law. This product should only be handled by licenced qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused as a drug, food and cosmetic.

T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper

T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper

$46.99

FREE Shipping for orders over $200

The T3 LIOTHYRONINE 200MCG/ML for sale here are intended for laboratory and research use only, unless otherwise explicitly stated. They are not intended for human ingestion or for use in products that may be ingested. Shake well before research.

What Is T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper?

Liothyronine (T3) is a synthetic iodothyronine and structurally similar to triiodothyronine, which is derived from thyroxine and is involved in transcriptional regulation mediated by thyroid hormone receptor. In the laboratory, T3 serves as a reference molecule for investigations relating to binding of thyroid receptors, activation of nuclear receptors and the resulting gene expression associated with the cellular regulation of energy balance, thermodynamic equilibria and macronutrient metabolism at the level of biochemistry.

Liothyronine was first characterized in the mid-20th century and has been heavily investigated by both pharmacological and molecular research. Compared with thyroxine (T4), T3 has higher receptor affinity and transcriptional activity and, therefore, is well-suited for comparative studies investigating iodothyronine signaling kinetics and bioavailability. At Element CRP, liquid T3 for sale is supplied exclusively for educational and laboratory research purposes and is not intended for human or animal use, ingestion, or clinical application.

Structure Of T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper

structure

From Pubchem

IUPAC Name:(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid
Synonyms: 3,3',5-Triiodo-L-thyronine, 6893-02-3, Tresitope
Molecular Formula: C15H12I3NO4
Molecular Weight: 650.97 g/mol
CAS Number: 15785-49-6
PubChem CID: 5920

T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper Uses In Research

Liothyronine (T3) and Thyroid Hormone Signaling Pathways

Liothyronine (T3) is studied in research settings as a high-affinity ligand for thyroid hormone receptors (TRα and TRβ), functioning as an agonist of these ligand-dependent transcription factors. Functional investigations focus on its role in regulating thyroid hormone–responsive gene networks, nuclear receptor dimerization, chromatin remodeling, and transcriptional activation via thyroid hormone response elements (TREs).

Within controlled laboratory systems, T3 is frequently used as a reference compound to examine differential receptor activation, feedback regulation within the hypothalamic–pituitary–thyroid axis, and comparative signaling cascades relative to other iodothyronines. These studies are limited to molecular and cellular observations and do not extend to physiological or clinical interpretation.

Liothyronine (T3) and Metabolic Gene Regulation

Research involving liothyronine includes examination of transcriptional programs associated with mitochondrial biogenesis, oxidative phosphorylation, and cellular metabolism. T3-mediated regulation of metabolic enzymes, transport proteins, and regulatory cofactors is analyzed to better understand thyroid hormone–dependent control of cellular energy homeostasis at the biochemical level.

These investigations utilize in vitro systems and computational modeling to characterize T3-induced changes in the expression of lipid- and carbohydrate-metabolism–related genes. Observations are confined to intracellular signaling behavior and do not imply systemic metabolic effects.

Liothyronine (T3) and Neuroendocrine Transcriptional Activity

Liothyronine is used in experimental studies to examine thyroid hormone receptor expression and activity in neuronal cell populations. Research focuses on receptor localization, transcriptional regulation of neurodevelopmental genes, and interactions between thyroid hormone signaling and other nuclear receptor pathways.

Additional studies investigate the influence of T3 on neurotransmitter-related gene expression and intracellular signaling pathways in neural model systems. These investigations are mechanistic and exploratory in nature and remain restricted to non-clinical experimental settings.

Liothyronine (T3) and Myelin-Associated Molecular Pathways

Experimental research has examined the role of thyroid hormone signaling in oligodendrocyte lineage development and myelin gene expression. Liothyronine has been used as a molecular probe to investigate transcriptional regulation of myelin-associated proteins, cytoskeletal organization, and maturation-related signal transduction pathways within laboratory-based experimental models.

These studies aim to clarify thyroid hormone–dependent regulatory mechanisms within central nervous system cellular frameworks, without reference to therapeutic application or disease modification.

Research Classification and Regulatory Status of Liothyronine (T3)

Liothyronine is a synthetic iodothyronine extensively characterized in molecular biology and endocrinology research. Any T3 supplied by Element CRP is strictly limited to laboratory and educational research purposes and is not intended for human or animal use, ingestion, or incorporation into pharmaceutical, dietary, or cosmetic products.

Researchers are responsible for ensuring that liothyronine is handled and utilized in compliance with applicable regulatory requirements and ethical research standards. Procurement is restricted to qualified insti

Referenced Citations

  1. Tariq, A., et al., Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life. South Med J, 2018. 111(6): p. 363-369.
  2. Bjerkreim, B.A., et al., Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy: A Randomized Crossover Study. Front Endocrinol (Lausanne), 2022. 13: p. 816566.
  3. P, M., et al., - Physiologic Effects of Levothyroxine and Liothyronine in the in Older Individuals. J Endocr Soc, 2021. 5(Suppl 1).
  4. Celi, F.S., et al., Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab, 2011. 96(11): p. 3466-74.
  5. Lisa J. Rosenthal, M.D. ,, Whitney S. Goldner, M.D. , and, and John P. O'Reardon, M.D., T3 Augmentation in Major Depressive Disorder: Safety Considerations. American Journal of Psychiatry, 2011. 168(10): p. 1035-1040.
  6. Touma, K.T.B., A.M. Zoucha, and J.R. Scarff, Liothyronine for Depression: A Review and Guidance for Safety Monitoring. Innov Clin Neurosci, 2017. 14(3-4): p. 24-29.
  7. Wooliscroft, L., et al., Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes. Multiple Sclerosis and Related Disorders, 2020. 41: p. 102015.
  8. Newsome, S.D., et al., A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS. Neurotherapeutics, 2023.
Molecular FormulaMolecular WeightCAS NumberSKU
C15H12I3NO4650.97 g/mol6893-02-3EL-T3

T3 Liothyronine is the synthetic form of triiodothyronine, the active thyroid hormone. As a small-molecule iodothyronine, it engages thyroid hormone receptors (THRa and THRß) — nuclear receptors regulating metabolic gene expression — and supports reliable behaviour across in vitro thyroid pharmacology research applications.

Cell-based research with T3 Liothyronine examines THR binding affinity, ligand-dependent transcriptional regulation, and metabolic gene expression in hepatocyte, cardiomyocyte, and adipocyte cell models. Standard readouts include TRE-driven reporter gene assays, target gene expression profiling (DIO1, MCT8, UCP1), and comparative pharmacology against other thyroid hormone analogues.

Element CRP supplies this product at 200mcg/mL × 30mL. USA-manufactured via chemical synthesis and verified at 99%+ purity by HPLC and Mass Spectrometry. Pre-mixed liquid solution in 30mL or 60mL bottle with dropper; ready for laboratory use. Store at 15-25°C, away from direct light.

WARNING: For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified research professionals only.

Catalog
Product List